AJANTA PHARMA LTD FDA Approval ANDA 215220

ANDA 215220

AJANTA PHARMA LTD

FDA Drug Application

Application #215220

Application Sponsors

ANDA 215220AJANTA PHARMA LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

002TABLET; ORAL50MG/1000MG0SITAGLIPTIN AND METFORMIN HYDROCHLORIDESITAGLIPTIN; METFORMIN HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1TA2022-05-31STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215220
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.